Post hoc analysis of two trials of ticagrelor monotherapy after PCI for ACS (2,248 propensity-matched patients): stopping aspirin within 1 month vs at 3 months was associated with fewer 1-year net events (3.2% vs 5.6%; HR 0.56), mainly less major bleeding.
Secondary analysisn = 2,248
Lee et al. Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials